Other pharmacologic agents that may affect bronchial hyperreactivity.
Although most asthmatic athletes can be adequately controlled by beta-adrenergic agents, sodium cromolyn, and/or theophylline, a few do not tolerate these medications or have suboptimal results. Cromolyn-like antiallergic drugs, newer antihistamine, antiserotonin, and antileukotriene agents as well as calcium channel blockers, antimuscarinics , alpha-adrenergic blockers, and new steroid preparations may be suitable for these individuals. Although efficacy has been demonstrated for a number of these new agents, much work remains to be done to evaluate thoroughly their potential pharmacologic effectiveness in exercise-induced asthma.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001250:Asthma, Exercise-Induced / Q000188:drug therapy*; D052160:Benzothiazoles; D019819:Budesonide; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D002867:Chromones / Q000627:therapeutic use; D003533:Cyproheptadine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007665:Ketotifen / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011282:Pregnenediones / Q000627:therapeutic use; D011398:Promethazine / Q000627:therapeutic use; D013892:Thioxanthenes / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use; D044004:Xanthones
D000317:Adrenergic alpha-Antagonists; D052160:Benzothiazoles; D002121:Calcium Channel Blockers; D002227:Carbazoles; D002867:Chromones; D010276:Parasympatholytics; D010879:Piperazines; D011282:Pregnenediones; D013892:Thioxanthenes; D014970:Xanthines; D044004:Xanthones; D003533:Cyproheptadine; D019819:Budesonide; C020486:proxicromil; C006656:azatadine; C016025:oxarbazole; C003468:tiaramide; D011398:Promethazine; C015408:oxatomide; C010134:doxantrazole; D007665:Ketotifen